Join
Live feed
·
PRReleasevia Quantisnow
Satsuma Pharmaceuticals Inc. logo

Satsuma Pharmaceuticals and SNBL Announce Three Abstracts on STS101 for the Acute Treatment of Migraine to be Presented at the American Headache Society's 65th Annual Scientific Meeting

ByQuantisnow·Wall Street's wire, on your screen.
STSA· Satsuma Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track STSA (Satsuma Pharmaceuticals Inc.) and more on Quantisnow.

Satsuma Pharmaceuticals and SNBL Announce Three Abstracts on STS101 for the Acute Treatment of Migraine to be Presented at the American Headache Society's 65th Annual Scientific Meeting | Quantisnow